Star Sports Medicine Co., Ltd. (HKG:1609)

Hong Kong · Delayed Price · Currency is HKD

172.00

-15.00 (-8.02%)

Jun 18, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Sale of Sports Medicine Products	402.75M	327.12M	238.54M	147.97M	73.01M
Sale of Sports Medicine Products Growth	23.12%	37.13%	61.21%	102.66%	176.49%
Total	402.75M	327.12M	238.54M	147.97M	73.01M
Total Growth	23.12%	37.13%	61.21%	102.66%	176.49%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Chinese Mainland	332.49M	306.27M	231.88M	-	-
Chinese Mainland Growth	8.56%	32.08%	-	-	-
Other Countries/Regions	70.27M	20.85M	6.67M	379.50K	17.70K
Other Countries/Regions Growth	236.97%	212.81%	1656.52%	2044.07%	-
China	-	-	-	147.59M	73.00M
China Growth	-	-	-	102.19%	176.42%
Total	402.75M	327.12M	238.54M	147.97M	73.01M
Total Growth	23.12%	37.13%	61.21%	102.66%	176.49%